The extracellular matrix: A dynamic niche in cancer progression
Open accessThe DOI matches its Crossref record; 143 of the 144 references it cites were found in a registry or an index.
Abstract
The local microenvironment, or niche, of a cancer cell plays important roles in cancer development. A major component of the niche is the extracellular matrix (ECM), a complex network of macromolecules with distinctive physical, biochemical, and biomechanical properties. Although tightly controlled during embryonic development and organ homeostasis, the ECM is commonly deregulated and becomes disorganized in diseases such as cancer. Abnormal ECM affects cancer progression by directly promoting cellular transformation and metastasis. Importantly, however, ECM anomalies also deregulate behavior of stromal cells, facilitate tumor-associated angiogenesis and inflammation, and thus lead to generation of a tumorigenic microenvironment. Understanding how ECM composition and topography are maintained and how their deregulation influences cancer progression may help develop new therapeutic interventions by targeting the tumor niche.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides its biochemical composition, such as intermolecular covalent cross-linkages, the ECM biophysical characteristics include its topography, stiffness/rigidity, molecular density, and tension [118].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This biochemical framework imparts key biophysical properties to the tumor tissue, including stiffness, porosity, insolubility, and molecular density [5,77,78,79]. These characteristics serve as biomechanical cues that modulate diverse cellular processes, such as migration, proliferation, polarity maintenance, and lineage specification [25,80].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [79]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“There is an extensive body of experimental data indicating that remodeling of the ECM promotes cancer invasion and metastasis [42, 43].”
From The hypoxic tumor microenvironment: A driving force for breast cancer progression (2016) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“The ECM is known to influence cell behavior in terms of cell migration, and anchorage, by serving as a medium to transmit external forces from environmental cues and even cell signaling throughout the entire lifespan of the cell and at critical phases in their lives [19,20].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“Mechanical properties, e.g., ECM stiffness, of the cell and tissue microenvironment are known to play an important role in cell survival [53,54], proliferation[55], migration[56], and tissue differentiation[57,58].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Self-citationMatrix elasticity directs stem cell lineage specification
Engler, A. J., Sen, S., Sweeney, H. L., & Discher, D. E. (2006) · Cell · doi:10.1016/j.cell.2006.06.044 · Cited by 13,915
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
Self-citationHuman mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
The extracellular matrix at a glance
Frantz, C., Stewart, K. M., & Weaver, V. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.023820 · Cited by 4,334
Self-citationCell Shape, Cytoskeletal Tension, and RhoA Regulate Stem Cell Lineage Commitment
McBeath, R., Pirone, D. M., Nelson, C. M., Bhadriraju, K., & Chen, C. S. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00075-9 · Cited by 4,180
Cited by
Items 601–700 of 1,013
Morgan, M. M., Johnson, B. P., Livingston, M. K., Schuler, L. A., Alarid, E. T., Sung, K. E., & Beebe, D. J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.05.007 · Cited by 75
Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond
Iqbal, J., Abbasi, B. A., Ahmad, R., Mahmood, T., Ali, B., Khalil, A. T., Kanwal, S., Shah, S. A., Alam, M. M., Badshah, H., et al. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9352-3 · Cited by 82
Boehnke, K., Falkowska-Hansen, B., Stark, H.-J., & Boukamp, P. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs136 · Cited by 74
TCR-engineered T cells to treat tumors: Seeing but not touching?
Debets, R., Donnadieu, E., Chouaïb, S., & Coukos, G. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.03.002 · Cited by 81
“The eposition of a dense ECM has long been recognized to support caner cell growth and metastatic dissemination [96].”
BackgroundThe expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer
Winslow, S., Lindquist, K. E., Edsjö, A., & Larsson, C. (2016) · BMC Cancer · doi:10.1186/s12885-016-2864-2 · Cited by 80
Chaudhry, G.-E.-S., Akim, A. M., Sung, Y. Y., & Muhammad, T. S. T. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2553-8_16 · Cited by 89
Yu, K.-X., Yuan, W.-J., Wang, H.-Z., & Li, Y. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03675-9 · Cited by 96
“Compared with ECM in normal tissues, the secretion of tumor-related ECM molecules leads to significant differences in TME composition and tissue, and alters the establishment of tumor niches, angiogenesis, and immune response, enhancing tumor resistance and exclusion in immunotherapy [8, 114].”
BackgroundNikitovic, D., Kouvidi, K., Karamanos, N. K., & Tzanakakis, G. N. (2013) · BioMed Research International · doi:10.1155/2013/929531 · Cited by 74
M1 aminopeptidases as drug targets: broad applications or therapeutic niche?
Drinkwater, N., Lee, J., Yang, W., Malcolm, T. R., & McGowan, S. (2017) · FEBS Journal · doi:10.1111/febs.14009 · Cited by 82
“Overexpression of APN has been observed on leukemic blasts in acute myeloid leukemia (AML) [61] , and compelling studies have implicated APN protease activity in tumorassociated processes, particularly angiogenesis and metastasis [62, 63] .”
Background3D hydrogel-based microwell arrays as a tumor microenvironment model to study breast cancer growth
Casey, J., Yue, X., Nguyen, T. D., Acun, A., Zellmer, V. R., Zhang, S., & Zorlutuna, P. (2017) · Biomedical Materials · doi:10.1088/1748-605x/aa5d5c · Cited by 74
Hou, S., Zhou, S., Qin, Z., Liu, Y., Han, X., Yao, S., & Ji, H. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.01.009 · Cited by 81
“0 DTD AJPA2577_proo dynamics are involved in cancer malignant progression, including angiogenesis and metastasis.(42) LOX, which catalyzes the final enzymatic reaction required for collagen cross-linking, is crucial for collagen deposition and stabilization of the ECM structural components.”
BackgroundMa, D., Liu, S., Lal, B., Wei, S., Wang, S., Zhan, D., Zhang, H., Lee, R. S., Gao, P., Lopez-Bertoni, H., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3125 · Cited by 72
Self‐Strengthening Adhesive Force Promotes Cell Mechanotransduction
Yu, L., Hou, Y. X., Xie, W., Cuellar‐Camacho, J. L., Wei, Q., & Haag, R. (2020) · Advanced Materials · doi:10.1002/adma.202006986 · Cited by 77
Tsutsui, K., Machida, H., Nakagawa, A., Ahn, K., Morita, R., Sekiguchi, K., Miner, J. H., & Fujiwara, H. (2021) · Nature Communications · doi:10.1038/s41467-021-22881-y · Cited by 77
Kuchnio, A., Moens, S., Bruning, U., Kuchnio, K., Cruys, B., Thienpont, B., Broux, M., Ungureanu, A. A., Leite de Oliveira, R., Bruyère, F., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.010 · Cited by 73
“Noteworthy, since remodeling of the matrix by CAFs enhances the activation of the CAFs themselves, a self-sustaining feed-forward loop of CAF activation and matrix remodeling is initiated that progressively aggravates malignancy (Lu et al., 2012).”
BackgroundInfluentialTumor Restrictions to Oncolytic Virus
Vähä-Koskela, M. J. V., & Hinkkanen, A. (2014) · Biomedicines · doi:10.3390/biomedicines2020163 · Cited by 84
Wang, K., Kievit, F. M., Florczyk, S. J., Stephen, Z. R., & Zhang, M. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b01032 · Cited by 73
Böckelmann, L. C., & Schumacher, U. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1702974 · Cited by 72
Bisphenol S induced epigenetic and transcriptional changes in human breast cancer cell line MCF-7
Huang, W., Zhao, C., Zhong, H., Zhang, S., Xia, Y., & Cai, Z. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.12.084 · Cited by 85
Cao, W., Liu, B., Xia, F., Duan, M., Hong, Y., Niu, J., Wang, L., Liu, Y., Li, C., & Cui, D. (2019) · Nanoscale · doi:10.1039/c9nr07947e · Cited by 73
The Engagement Between MDSCs and Metastases: Partners in Crime
Trovato, R., Canè, S., Petrova, V., Sartoris, S., Ugel, S., & Sanctis, F. D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00165 · Cited by 79
“Moreover, ECM structure and composition can influence many aspects of MDSC behaviors, including infiltration, differentiation, and function generating a sort of vicious cycle that favors tumor growth and dissemination (113).”
BackgroundMigration of Cytotoxic T Lymphocytes in 3D Collagen Matrices
Sadjadi, Z., Zhao, R., Hoth, M., Qu, B., & Rieger, H. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.10.020 · Cited by 82
Breast tumor-on-chip models: From disease modeling to personalized drug screening
Bano, S., Dahiya, U. R., Mishra, S., Ayache, J., Casquillas, G. V., Caballero, D., Reis, R. L., & Kundu, S. C. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.057 · Cited by 83
Mechanical homeostasis in tissue equivalents: a review
Eichinger, J. F., Haeusel, L. J., Paukner, D., Aydin, R. C., Humphrey, J. D., & Cyron, C. J. (2021) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-021-01433-9 · Cited by 81
Miyoshi, H., & ADACHI, T. (2014) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2013.0728 · Cited by 79
Regulation of Stem Cell Fate by Nanomaterial Substrates
Mashinchian, O., Turner, L.-A., Dalby, M. J., Laurent, S., Shokrgozar, M. A., Bonakdar, S., Imani, M., & Mahmoudi, M. (2015) · Nanomedicine · doi:10.2217/nnm.14.225 · Cited by 73
Loupakis, F., Cremolini, C., Yang, D., Salvatore, L., Zhang, W., Wakatsuki, T., Bohanes, P. O., Schirripa, M., Benhaïm, L., Lonardi, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066774 · Cited by 74
“The so called ‘‘niche’’ [7–8], including endothelial and mesenchimal cells, plays a central role in the growth of new vessels, that is therefore a largely host-mediated, besides tumor-mediated, phenomenon.”
Failmezger, H., Muralidhar, S., Rullan, A., de Andrea, C. E., Sahai, E. A., & Yuan, Y. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2268 · Cited by 86
Dynamic interplay between cell membrane tension and clathrin‐mediated endocytosis
Djakbarova, U., Madraki, Y., Chan, E. T., & Kural, C. (2021) · Biology of the Cell · doi:10.1111/boc.202000110 · Cited by 71
“…development, as well as fibroblastic transdifferentiations that lead to cardiovascular disorders and cancer metastasis [Dufort et al., 2011, Liu et al., 2007, Roy et al., 2000, Kaden et al., 2005, Edep et al., 2000, Pho et al., 2008, Calvo et al., 2013, Lu et al., 2012, Bergert et al., 2020].”
BackgroundTargeting type I collagen for cancer treatment
Shi, R., Zhang, Z., Zhu, A.-K., Xiong, X., Zhang, J., Xu, J., Sy, M., & Li, C. (2022) · International Journal of Cancer · doi:10.1002/ijc.33985 · Cited by 81
“Critically, the ECM guides cancer progression by providing signals to cancer cells to modulate their biochemical properties and their behavior.(6,7) Collagen is the most abundant component in the ECM.”
BackgroundFan, S., Wang, Y., Lu, J. L., Zheng, Y., Wu, D., Zhang, Z., Shan, Q., Hu, B., Li, M., & Cheng, W. P. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24978 · Cited by 71
“The ECM maintains tissue polarity and architecture and prevents cancer cell invasion [Lu et al., 2012].”
BackgroundExtracellular chloride signals collagen IV network assembly during basement membrane formation
Cummings, C. F., Pedchenko, V. K., Brown, K. L., Colon, S., Rafi, M., Jones‐Paris, C. R., Pokydeshava, E., Liu, M., Pastor-Pareja, J. C., Stothers, C. L., et al. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201510065 · Cited by 77
“Basement membranes (BMs) are hallmarks of the cellular microenvironment of epithelial (Hagios et al., 1998; Lu et al., 2012), endothelial (Rhodes and Simons, 2007), muscle (Campbell and Stull, 2003; Sanes, 2003), fat (Sillat et al., 2012), Schwann (Court et al., 2006), and decidua cells (Fig.”
BackgroundModulating cell response on cellulose surfaces; tunable attachment and scaffold mechanics
Courtenay, J. C., Deneke, C. F., Lanzoni, E. M., Costa, C. A. R., Bae, Y., Scott, J. L., & Sharma, R. I. (2017) · Cellulose · doi:10.1007/s10570-017-1612-3 · Cited by 75
“Cell function on the scaffold can be directly influenced by: cell and ECM interactions modulated via transmembrane receptors (Lu et al. 2012), soluble growth factors (Lieberman et al. 2002), and the mechanical properties of the biomaterial (Reddi 2003).”
BackgroundEmerging nanomedicines for anti-stromal therapy against desmoplastic tumors
Han, X., Xu, Y., Geranpayehvaghei, M., Anderson, G. J., Li, Y., & Nie, G. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119745 · Cited by 71
Vascular Mechanobiology: Towards Control of In Situ Regeneration
van Haaften, E. E., Bouten, C. V. C., & Kurniawan, N. A. (2017) · Cells · doi:10.3390/cells6030019 · Cited by 77
“First, since cells are able to actively remodel the surrounding micro-environment, the tissue mechanical properties do not stay constant [134,135].”
Girard, C. A., Lecacheur, M., Ben Jouira, R., Berestjuk, I., Diazzi, S., Prod'homme, V., Mallavialle, A., Larbret, F., Gesson, M., Schaub, S., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2914 · Cited by 70
“The ECM is a dynamic network of macromolecules with distinctive biochemical and mechanical properties that plays a major role in establishing tumor niches (1).”
BackgroundFlores-Torres, S., Peza-Chavez, O., Kuasne, H., Munguia-López, J. G., Kort-Mascort, J., Ferri, L. E., Jiang, T., Rajadurai, C. V., Park, M., Sangwan, V., et al. (2021) · Biofabrication · doi:10.1088/1758-5090/abdb87 · Cited by 81
“The additional ECM components are known to influence cell phenotype [38], functionality [39], and malignancy [40–42].”
Blouw, B., Patel, M., Iizuka, S., Abdullah, C., You, W. K., Huang, X., Li, J., Díaz, B., Stallcup, W. B., & Courtneidge, S. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121003 · Cited by 70
“Tumor cells are obliged to penetrate, remodel and degrade the extracellular matrix (ECM) in order to invade and metastasize [1].”
BackgroundStampolidis, P., Ullrich, A., & Iacobelli, S. (2013) · Oncogene · doi:10.1038/onc.2013.548 · Cited by 74
Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis
Teitz, T., Inoue, M., Valentine, M. B., Zhu, K., Rehg, J. E., Zhao, W. M., Finkelstein, D., Wang, Y., Johnson, M. D., Calabrese, C. R., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2681 · Cited by 79
“These ECM changes are likely to cause increased stiffness of the primary tumor and changes in mechanotransduction properties which have been shown in different tumor types to correlate with advanced stage of disease (42-44).”
BackgroundEmerging therapeutic targets in metastatic progression: A focus on breast cancer
Li, Z., & Kang, Y. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.003 · Cited by 75
New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging
Brighton, H. E., Angus, S. P., Bo, T., Roques, J., Tagliatela, A. C., Darr, D. B., Karagoz, K., Sciaky, N., Gatza, M. L., Sharpless, N. E., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1653 · Cited by 70
“The ECM in tumors is highly dynamic, and de-regulation of collagen crosslinking within the ECM has been shown to play a causative role in cancer pathogenesis (47,48).”
BackgroundCrocetti, L., Quinn, M. T., Schepetkin, I. A., & Giovannoni, M. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1630379 · Cited by 75
Tumor-penetrating peptide for systemic targeting of Tenascin-C
Lingasamy, P., Tobi, A., Kurm, K., Kopanchuk, S., Sudakov, A., Salumäe, M., Rätsep, T., Asser, T., Bjerkvig, R., & Teesalu, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-62760-y · Cited by 69
Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression
Murdamoothoo, D., Sun, Z., Yilmaz, A., Riegel, G., Fayçal, C. A., Deligne, C., Velázquez-Quesada, I., Erne, W., Nascimento, M., Mörgelin, M., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013270 · Cited by 72
“Tumors are complex ecosystems where the matrix is an instrumental component not only providing architectural but also signaling cues to cells (Lu et al, 2012; Pickup et al, 2014).”
BackgroundSingh, M., Close, D. A., Mukundan, S., Johnston, P. A., & Sant, S. (2015) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2015.662 · Cited by 69
GPR56 Inhibits Melanoma Growth by Internalizing and Degrading Its Ligand TG2
Yang, L., Friedland, S. C., Corson, N., & Xu, L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1268 · Cited by 78
Mechanical Characterization of a Dynamic and Tunable Methacrylated Hyaluronic Acid Hydrogel
Ondeck, M. G., & Engler, A. J. (2016) · Journal of Biomechanical Engineering · doi:10.1115/1.4032429 · Cited by 76
Kurashige, J., Hasegawa, T., Niida, A., Sugimachi, K., Deng, N., Mima, K., Uchi, R., Sawada, G., Takahashi, Y., Eguchi, H., et al. (2016) · Scientific Reports · doi:10.1038/srep22371 · Cited by 78
Glycoproteins and glycoproteomics in pancreatic cancer
Pan, S., Brentnall, T. A., & Chen, R. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i42.9288 · Cited by 71
Kapetas, P., Clauser, P., Woitek, R., Wengert, G., Lázár, M., Pinker, K., Helbich, T. H., & Baltzer, P. (2019) · Investigative Radiology · doi:10.1097/rli.0000000000000543 · Cited by 80
Heterogeneity and Plasticity of Breast Cancer Stem Cells
Sousa, B., Ribeiro, A. S., & Paredes, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-14366-4_5 · Cited by 78
Zhang, R., Ma, M., Lin, X.-H., Liu, H.-H., Chen, J., Chen, J., Gao, D.-M., Cui, J.-F., Ren, Z.-G., & Chen, R.-X. (2018) · BMC Cancer · doi:10.1186/s12885-018-4820-9 · Cited by 68
Breast tumor stroma: A driving force in the development of resistance to therapies
Majidinia, M., & Yousefi, B. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12893 · Cited by 68
Identification of a Druggable Pathway Controlling Glioblastoma Invasiveness
Pencheva, N., de Gooijer, M. C., Vis, D. J., Wessels, L. F. A., Würdinger, T., van Tellingen, O., & Bernards, R. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.036 · Cited by 77
Matos, A. I., Carreira, B., Peres, C., Moura, L. I. F., Conniot, J., Fourniols, T., Scomparin, A., Martínez-Barriocanal, Á., Arango, D., Conde, J. P., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.017 · Cited by 68
Extracellular matrix stiffness and Wnt/β-catenin signaling in physiology and disease
Astudillo, P. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200026 · Cited by 68
Yin, W., Zhu, H., Tan, J., Xin, Z., Zhou, Q., Cao, Y., Wu, Z., Wang, L., Zhao, M. F., Jiang, X., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01982-0 · Cited by 75
“Increased deposition of collagen alone or in combination facilitates cancer cell proliferation, migration, and metastasis by interfering with cell polarity, cellcell adhesion and ultimately resulting in amplification of the growth factor signaling [36].”
BackgroundSilvani, G., Basirun, C., Wu, H., Mehner, C., Poole, K., Bradbury, P., & Chou, J. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100106 · Cited by 80
Control of cancer formation by intrinsic genetic noise and microenvironmental cues
Brock, A., Krause, S., & Ingber, D. E. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3959 · Cited by 74
Kumar, S., Kapoor, A., Desai, S., Inamdar, M. M., & Sen, S. (2016) · Scientific Reports · doi:10.1038/srep19905 · Cited by 82
Song, Y. H., Warncke, C., Choi, S. J., Choi, S., Chiou, A. E., Ling, L., Liu, H.-Y., Daniel, S., Antonyak, M. A., Cerione, R. A., et al. (2017) · Matrix Biology · doi:10.1016/j.matbio.2016.11.008 · Cited by 67
Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer
Tian, J., Hachim, M. Y., Hachim, I. Y., Dai, M., Lo, C., Raffa, F. A., Ali, S., & Lebrun, J. J. (2017) · Scientific Reports · doi:10.1038/srep40258 · Cited by 72
Signaling Pathways Driving Aberrant Splicing in Cancer Cells
Gonçalves, V., Pereira, J., & Jordan, P. (2017) · Genes · doi:10.3390/genes9010009 · Cited by 72
“Changes in matrix composition, 3D-organization or matrix stiffness communicate with a diversity of cell surface receptors [113,114] and result in a signaling response [115], including changes in alternative splicing.”
BackgroundOlofsson, K., Carannante, V., Ohlin, M., Frisk, T., Kushiro, K., Takai, M., Lundqvist, A., Önfelt, B., & Wiklund, M. (2018) · Lab on a Chip · doi:10.1039/c8lc00537k · Cited by 67
TIMP-2 suppresses tumor growth and metastasis in murine model of triple-negative breast cancer
Peeney, D., Jensen, S., de Castro, N. P., Kumar, S., Noonan, S., Handler, C., Kuznetsov, A. V. K., Shih, J. H., Tran, A. D., Salomon, D. S., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz172 · Cited by 70
Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets
Talib, W. H., Alsayed, A. R., Farhan, F., & Kury, L. T. A. (2020) · Molecules · doi:10.3390/molecules25184282 · Cited by 79
Redmond, J., McCarthy, H. O., Buchanan, P., Levingstone, T. J., & Dunne, N. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.111944 · Cited by 80
“The tumour-ECM interaction is fundamental in directing and controlling many aspects of cancer development and progression [20,22] and is absent in 2D culture models.”
BackgroundExtracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer
Zhao, Y., Zheng, X., Zheng, Y., Chen, Y., Fei, W., Wang, F., & Zheng, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.650453 · Cited by 86
“Evidence suggests that ECM components are dynamic during cancer progression and may promote metastatic spread (9).”
BackgroundThe Role of Vascular Cells in Pancreatic Beta-Cell Function
Burganova, G., Bridges, C. A., Thorn, P., & Landsman, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.667170 · Cited by 73
Arming oncolytic viruses to leverage antitumor immunity
de Gruijl, T. D., Janssen, A. B., & van Beusechem, V. W. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1044433 · Cited by 79
“In addition to the cellular component, the extracellular matrix (ECM) component also plays a role in the development of malignancies, providing signals for cell survival and proliferation [13].”
BackgroundBarcus, C. E., Holt, E. C., Keely, P. J., Eliceiri, K. W., & Schuler, L. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116891 · Cited by 70
“The increased mechanical stiffness leads to activation of signaling pathways including FAK and SRC-family kinases (SFK) that promote invasion and tumor progression [13–15].”
BackgroundHeissig, B., Dhahri, D., Eiamboonsert, S., Salama, Y., Shimazu, H., Munakata, S., & Hattori, K. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2035-7 · Cited by 71
Protean proteases: at the cutting edge of lung diseases
Taggart, C. C., Mall, M. A., Lalmanach, G., Cataldo, D. D., Ludwig, A., Janciauskiene, S. M., Heath, N., Meiners, S., Overall, C. M., Schultz, C., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01200-2015 · Cited by 75
“Dysregulation of MMP activity is a characteristic feature of organ fibrosis [88] including in the lung [89] and malignant tumors [1, 90].”
BackgroundStaunton, J. R., So, W. Y., Paul, C. D., & Tanner, K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814271116 · Cited by 71
Shah, S., & D’Souza, G. G. M. (2025) · Cells · doi:10.3390/cells14100732 · Cited by 83
“This biochemical framework imparts key biophysical properties to the tumor tissue, including stiffness, porosity, insolubility, and molecular density [5,77–79].”
InfluentialRomano, G., Santi, L., Bianco, M. R., Giuffrè, M. R., Pettinato, M., Bugarin, C., Garanzini, C., Savarese, L., Leoni, S., Cerrito, M. G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7895 · Cited by 66
“5FU alone also strongly induced FN1 , a protein involved in ECM reorganization and cell to matrix adhesion processes [36, 37], but FN1 up-regulation was abolished by the co-treatment of 5FU and LiCl or 5FU and SB431542 (Figure 5).”
Blacher, S., Erpicum, C., Lenoir, B., Paupert, J., Moraes, G., Ormenese, S., Bullinger, E., & Noel, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097019 · Cited by 66
Bertero, T., Cottrill, K. A., Annis, S., Bhat, B., Gochuico, B. R., Osorio, J. C., Rosas, I., Haley, K. J., Corey, K. E., Chung, R. T., et al. (2015) · Scientific Reports · doi:10.1038/srep18277 · Cited by 68
“This was quantified as the average of two values: (1) the fraction of network genes that were shared with the fibrosis network and (2) the fraction of the highest possible rank achieved by miR-130/301 [1 – rank130/rankMAX].”
MethodA new path to platelet production through matrix sensing
Abbonante, V., Buduo, C. A. D., Gruppi, C., Maria, C. D., Spedden, E., Acutis, A. D., Staii, C., Raspanti, M., Vozzi, G., Kaplan, D. L., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.161562 · Cited by 78
“However, some patho-physiological conditions, such as aging or augmented bone marrow fibrosis determine an increase of ECM component rigidity, causing tissue function alterations.(57,58) Interestingly, it is known that platelet count is inversely correlated with age and that in the late stages of primary myelofibrosis…”
BackgroundFatherree, J. P., Guarin, J. R., McGinn, R. A., Naber, S. P., & Oudin, M. J. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-1823 · Cited by 69
“ECM organization and composition is commonly dysregulated in solid tumors (18).”
BackgroundCancer immune exclusion: breaking the barricade for a successful immunotherapy
Bruni, S., Mercogliano, M. F., Mauro, F. L., Russo, R. I. C., & Schillaci, R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1135456 · Cited by 79
“The latter contains different types of polymers such as polysaccharides, like hyaluronan and chondroitin sulfate, biglycan and perlecan, and fibrous proteins, like collagen and fibronectin that provide structure to the matrix and participate in cell-cell interactions (67).”
BackgroundQin, Z., Robichaud, P., He, T., Fisher, G. J., Voorhees, J. J., & Quan, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115402 · Cited by 64
Qin, Z., Voorhees, J. J., Fisher, G. J., & Quan, T. (2014) · Aging Cell · doi:10.1111/acel.12265 · Cited by 69
Microenvironment, tumor cell plasticity, and cancer
Faurobert, E., Bouin, A., & Albigès‐Rizo, C. (2014) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000154 · Cited by 67
“ECM is the major component of the tumoral niche through a network of macromolecules including proteins, glycoproteins, proteoglycans, and polysaccharides with distinct biochemical and mechanical properties known to regulate cell behavior and tissue organization [7].”
BackgroundStaunton, J. R., Vieira, W. D., Fung, K. L., Lake, R. G., Devine, A., & Tanner, K. (2016) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-016-0460-9 · Cited by 64
Linking Extracellular Matrix Agrin to the Hippo Pathway in Liver Cancer and Beyond
Chakraborty, S., & Hong, W. (2018) · Cancers · doi:10.3390/cancers10020045 · Cited by 65
“From a clinical perspective, ECM rigidity is well correlated with malignancy and cancer progression resulting in poor patient outcome [1,91].”
BackgroundMRI analysis to map interstitial flow in the brain tumor microenvironment
Kingsmore, K. M., Vaccari, A., Abler, D., Cui, S., Epstein, F. H., Rockne, R. C., Acton, S. T., & Munson, J. M. (2018) · APL Bioengineering · doi:10.1063/1.5023503 · Cited by 71
Patient-derived scaffolds uncover breast cancer promoting properties of the microenvironment
Landberg, G., Fitzpatrick, P., Isakson, P., Jonasson, E., Karlsson, J., Larsson, E., Svanström, A., Rafnsdottir, S., Persson, E., Gustafsson, A., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119705 · Cited by 65
Labouta, H. I., Gomez-Garcia, M. J., Sarsons, C. D., Nguyen, T., Kennard, J., Ngo, W., Terefe, K., Iragorri, N., Lai, P. K., Rinker, K. D., et al. (2018) · RSC Advances · doi:10.1039/c7ra13438j · Cited by 75
Collagen Kinase Receptors as Potential Therapeutic Targets in Metastatic Colon Cancer
Lafitte, M., Sirvent, A., & Roche, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00125 · Cited by 68
CAR T Cell Locomotion in Solid Tumor Microenvironment
Nguyen, D., Ogando‐Rivas, E., Liu, R., Wang, T., Rubin, J. A., Jin, L., Tao, H., Sawyer, W. W., Méndez‐Gómez, H. R., Cascio, M., et al. (2022) · Cells · doi:10.3390/cells11121974 · Cited by 69
Ryoo, H., Kimmel, H., Rondo, E., & Underhill, G. H. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10627 · Cited by 76
“…environment sensing tissue stiffness and elasticity, 5 – 9 extracellular matrix composition and degradability, 6,7,10 cell – cell interactions, 11 – 13 and soluble factors (nutrients and growth factors) 4,14,15 which can be altered in disease and promote further disease progression 5,16 (Figure 1).”
BackgroundMa, Y., Yang, I., Tsai, H., Huang, C., Juo, S. H., & Wang, J. (2013) · DNA and Cell Biology · doi:10.1089/dna.2013.2161 · Cited by 69
“The dynamic environmental conditions, such as nutrient, oxygen, acidity, specific stromal cell components, and extracellular matrix, play important role in cancer development, progress, and drug resistance (Lu et al., 2012).”
BackgroundWithin tumors, interactions between T cells and tumor cells are impeded by the extracellular matrix
Salmon, H., & Donnadieu, E. (2012) · OncoImmunology · doi:10.4161/onci.20239 · Cited by 64
Mayrhofer, M., Gourain, V., Reischl, M., Affaticati, P., Jenett, A., Joly, J., Benelli, M., Demichelis, F., Poliani, P. L., Sieger, D., et al. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.026500 · Cited by 81
“As a component of the tumour microenvironment, the extracellular matrix has a significant impact on the development, progression, and therapy response in tumours (Giussani et al., 2015; Lu et al., 2012).”
Lugo-Cintrón, K. M., Ayuso, J. M., White, B. R., Harari, P. M., Ponik, S. M., Beebe, D. J., Gong, M. M., & Virumbrales-Muñoz, M. (2020) · Lab on a Chip · doi:10.1039/d0lc00099j · Cited by 64
Willumsen, N., Ali, S. M., Leitzel, K., Drabick, J. J., Yee, N., Polimera, H. V., Nagabhairu, V., Krecko, L., Ali, A., Maddukuri, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56268-3 · Cited by 63
Xiong, Y., Zhang, X., Zhu, J., Zhang, Y., Pan, Y., Wu, Y. Z., Zhao, J., Liu, J., Lu, Y., Liang, H., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01166-5 · Cited by 73
“Extensive studies have demonstrated that ECM and collagens can cross-talk with cancer cells, including cancer stem cells, to promote tumor progression [51, 52].”
BackgroundMechanobiology of organelles: illuminating their roles in mechanosensing and mechanotransduction
Phuyal, S., Romani, P., Dupont, S., & Farhan, H. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.05.001 · Cited by 68
Metadata
- Authors
- Lu, P., Weaver, V. M., & Werb, Z.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Werb, Zena
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2012-02-20
- Volume
- 196
- Issue
- 4
- Pages
- 395-406
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3283993
- OpenAlex
- W2132566055
- Semantic Scholar
- 3fca40f6a3c524e3208a0f95c34cd67f453bae03
- Cited by
- 3,024
- References
- 144
- Citations by year
- 2026: 136 · 2025: 155 · 2024: 155 · 2023: 214 · 2022: 207 · 2021: 290 · 2020: 284 · 2019: 268 · 2018: 275 · 2017: 251 · 2016: 254 · 2015: 191 · 2014: 180 · 2013: 117 · 2012: 43
- FWCI
- 15.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA138818, P50CA058207, R01CA057621)
- National Institute of Environmental Health Sciences (U01ES019458)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R03HD060807)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- extracellular matrix, tumor microenvironment, tumor progression, metastasis, cell transformation, stromal cells, tumor angiogenesis, inflammation, ECM composition, ECM-targeted therapy
- MeSH terms
- Extracellular Matrix, Humans, Neoplasms, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.